Gilead Sciences, Inc.

GILD · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$9,991,000$6,085,000$5,412,000$5,338,000
Short-Term Investments$1,577,000$1,179,000$973,000$1,182,000
Receivables$4,420,000$4,660,000$4,777,000$4,493,000
Inventory$1,710,000$1,787,000$1,507,000$1,618,000
Other Curr. Assets$1,475,000$2,374,000$1,774,000$2,141,000
Total Curr. Assets$19,173,000$16,085,000$14,443,000$14,772,000
Property Plant & Equip (Net)$5,414,000$5,317,000$5,475,000$5,121,000
Goodwill$8,314,000$8,314,000$8,314,000$8,332,000
Intangibles$19,948,000$26,454,000$28,893,000$33,455,000
Long-Term Investments$0$1,163,000$1,245,000$1,309,000
Tax Assets$0$0$0$0
Other NC Assets$6,146,000$4,792,000$4,800,000$4,963,000
Total NC Assets$39,822,000$46,040,000$48,727,000$53,180,000
Other Assets$0$0$1,000$0
Total Assets$58,995,000$62,125,000$63,171,000$67,952,000
Liabilities
Payables$833,000$550,000$905,000$705,000
Short-Term Debt$1,815,000$1,798,000$2,273,000$1,516,000
Tax Payable$830,000$1,208,000$959,000$539,000
Deferred Revenue$0$0$0$0
Other Curr. Liab.$8,526,000$7,724,000$7,101,000$8,850,000
Total Curr. Liab.$12,004,000$11,280,000$11,238,000$11,610,000
LT Debt$24,896,000$23,189,000$22,957,000$25,179,000
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$724,000$1,588,000$2,673,000$4,356,000
Other NC Liab.$2,125,000$3,319,000$5,094,000$5,743,000
Total NC Liab.$27,745,000$28,096,000$30,724,000$35,278,000
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$39,749,000$39,376,000$41,962,000$46,888,000
Equity
Pref Stock$0$0$0$0
Common Stock$1,000$1,000$1,000$1,000
Retained Earnings$11,497,000$16,304,000$15,687,000$16,324,000
AOCI$132,000$28,000$2,000$83,000
Other Equity$7,700,000$6,500,000$5,550,000$4,661,000
Total Equity$19,330,000$22,833,000$21,240,000$21,069,000
Supplemental Information
Minority Interest-$84,000-$84,000-$31,000-$5,000
Total Liab. & Tot. Equity$58,995,000$62,125,000$63,171,000$67,952,000
Net Debt$16,720,000$18,902,000$19,818,000$21,357,000